Meritage Pharma Report issue

For profit Phase 2
Founded: San Diego CA United States (2008)
Status: Acquired by Shire (2015) → now Takeda (2018)

Organization Overview

First Clinical Trial
2008
NCT00638456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Meritage Pharma, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

budesonide (rhinocort) (1 trial)

lansoprazole (prevacid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eosinophilic Esophagitis (Phase 2)

Esophagitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2